Royal Bank of Canada’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Royal Bank of Canada’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-2,000	Closed	-$48K	–	6377
2014 Q2	$48K	Sell	2,000 -71,058	-97%	-$741K	﹤0.01%	4873
2014 Q1	$440K	Buy	73,058 +65,458	+861%	+$456K	﹤0.01%	3445
2013 Q4	$46K	Sell	7,600 -12,860	-63%	-$59.5K	﹤0.01%	4937
2013 Q3	$106K	Sell	20,460 -25,269	-55%	-$111K	﹤0.01%	4447
2013 Q2	$166K	Buy	+45,729	New	+$187K	﹤0.01%	4007

Royal Bank of Canada's IDIX Position: Q3 2014 in Review

Royal Bank of Canada sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 2,000 shares — an estimated $48K sold.

Royal Bank of Canada first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $440K in Q1 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Royal Bank of Canada reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Royal Bank of Canada sold 2,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $48K.
Royal Bank of Canada first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Royal Bank of Canada's IDENIX PHARMACEUTICALS INC position peaked at $440K in Q1 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Royal Bank of Canada's 13F filing for Q3 2014, filed 14 Nov 2014.